Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 484.01 USD 0.11% Market Closed
Market Cap: 124.3B USD

Intrinsic Value

The intrinsic value of one VRTX stock under the Base Case scenario is 283.4 USD. Compared to the current market price of 484.01 USD, Vertex Pharmaceuticals Inc is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VRTX Intrinsic Value
283.4 USD
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Vertex Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
VRTX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VRTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Vertex Pharmaceuticals Inc
NASDAQ:VRTX
US
Biotechnology
Market Cap
124.4B USD
IPO
Jul 24, 1991
US
Biotechnology
Market Cap
124.4B USD
IPO
Jul 24, 1991
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Vertex remains heavily dependent on its cystic fibrosis portfolio, and any slowdown in CF sales or an unexpected competitor breakthrough could significantly impact its top line.

Bull Theses

Vertex’s CF franchise holds a dominant market position, with new therapies continually maintaining or expanding its share in this high-value therapeutic area.

Show More Less
How do you feel about VRTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Vertex Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vertex Pharmaceuticals Inc

Current Assets 9.6B
Cash & Short-Term Investments 7.7B
Receivables 1.6B
Other Current Assets 324.8m
Non-Current Assets 12.9B
Long-Term Investments 5.2B
PP&E 2.6B
Intangibles 1.9B
Other Non-Current Assets 3.3B
Efficiency

Free Cash Flow Analysis
Vertex Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vertex Pharmaceuticals Inc

Revenue
11B USD
Cost of Revenue
-1.5B USD
Gross Profit
9.5B USD
Operating Expenses
-5.1B USD
Operating Income
4.4B USD
Other Expenses
-4.9B USD
Net Income
-535.6m USD
Fundamental Scores

VRTX Profitability Score
Profitability Due Diligence

Vertex Pharmaceuticals Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

Vertex Pharmaceuticals Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

VRTX Solvency Score
Solvency Due Diligence

Vertex Pharmaceuticals Inc's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

96/100
Solvency
Score

Vertex Pharmaceuticals Inc's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VRTX Price Targets Summary
Vertex Pharmaceuticals Inc

Wall Street analysts forecast VRTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRTX is 512.28 USD with a low forecast of 333.3 USD and a high forecast of 645.75 USD.

Lowest
Price Target
333.3 USD
31% Downside
Average
Price Target
512.28 USD
6% Upside
Highest
Price Target
645.75 USD
33% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vertex Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VRTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VRTX Insider Trading
Buy and sell transactions by insiders

VRTX News

Other Videos
What is the Intrinsic Value of one VRTX stock?

The intrinsic value of one VRTX stock under the Base Case scenario is 283.4 USD.

Is VRTX stock undervalued or overvalued?

Compared to the current market price of 484.01 USD, Vertex Pharmaceuticals Inc is Overvalued by 41%.

Back to Top